The G Protein Coupled Bile Acid Receptor 1 pipeline drugs market research report outlays comprehensive information on the G Protein Coupled Bile Acid Receptor 1 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA), and molecule type. GlobalData’s report assesses the drugs in the G Protein Coupled Bile Acid Receptor 1 pipeline by therapy areas, indications, stages, MoA, RoA, molecule type and the key players in the development pipeline. Buy the report here.
The report also covers products from therapy areas such as Immunology, Metabolic Disorders, Dermatology, and Infectious Disease which include the indications Inflammation, Obesity, Type 2 Diabetes, Atopic Dermatitis (Atopic Eczema), Sepsis, and Coronavirus Disease 2019 (COVID-19) Pneumonia. It also reviews key players involved in G Protein Coupled Bile Acid Receptor 1 targeted therapeutics development with respective active and dormant or discontinued products.
The G Protein Coupled Bile Acid Receptor 1 pipeline targets constitutes close to nine molecules. Out of which, approximately seven molecules are developed by companies and the remaining by the universities/institutes. The molecules developed by companies in Phase III, Phase II, Preclinical, and Discovery stages are 1, 1, 3, and 2 respectively. Similarly, the universities portfolio in Preclinical comprises 2 molecule.
G Protein Coupled Bile Acid Receptor 1 overview
G protein-coupled bile acid receptor 1 (GPBAR1) is a protein encoded by the GPBAR1 gene. It is a receptor for bile acid. Bile acid-binding induces its internalization, activation of extracellular signal-regulated kinase and intracellular cAMP production. It is involved in the suppression of macrophage functions by bile acids.
For a complete picture of G Protein Coupled Bile Acid Receptor 1’s drug pipeline, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.